Lm. Godsel et al., UTILITY OF RECOMBINANT FLAGELLAR CALCIUM-BINDING PROTEIN FOR SERODIAGNOSIS OF TRYPANOSOMA-CRUZI INFECTION, Journal of clinical microbiology, 33(8), 1995, pp. 2082-2085
The protozoan Trypanasoma cruzi is the causative agent of Chagas' dise
ase, a major public health problem in Latin America and of growing con
cern in the United States as the number of infected immigrants increas
es, There is currently no testing of U.S. blood products for T. cruzi
infection, and the best tests available, although highly sensitive, ar
e not of high enough specificity to be useful for widespread screening
of the blood supply in this country. Among the parasite antigens dete
cted by sera of infected humans and mice, those in the range of 24 to
26 kDa are particularly reactive. With an aim of developing a sensitiv
e, specific, recombinant antigen-based serologic test for T. cruzi inf
ection, we used two antibody reagents specific for these 24- to 26-kDa
antigens to isolate cDNA clones from a T. cruzi expression library. O
ne clone was found to encode a previously characterized T. cruzi antig
en, a 24-kDa flagellar calcium-binding protein (FCaBP), Recombinant FC
aBP was found to be a sensitive, specific reagent for distinguishing T
. cruzi-infected individuals from uninfected persons, and it therefore
could potentially be used for screening purposes, especially if combi
ned with other recombinant T. cruzi antigens that have similarly high
degrees of diagnostic sensitivity and specificity.